Drug recall · December 17, 2014
Tikosyn recall
Why: Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDC 0069-5800-60), Rx Only, Manufactured by Pfizer Labs, Division of Pfizer, Inc., NY, NY 10017.
- Lots / codes
Lot # a) H79652, Exp. 10/15; b) H79653, Exp. 10/15
- Quantity
- 31,569 HDPE Bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Pfizer shipped the affected product to 4,447 direct accounts. No federal government accounts received the affected product directly from Pfizer Inc.
- Initiated
- December 3, 2014 · Voluntary: Firm initiated
- Classified
- December 9, 2014
- Reported
- December 17, 2014
- Ended
- September 27, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tikosyn
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.